Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Should we lower cholesterol as much as possible?

× No keyword cloud information.

22 in total

1. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems.

Authors: H Sinzinger; J O'Grady
Journal: Br J Clin Pharmacol Date: 2004-04 Impact factor: 4.335

2. Rhode Island physicians' recognition and reporting of adverse drug reactions.

Authors: H D Scott; S E Rosenbaum; W J Waters; A M Colt; L G Andrews; J P Juergens; G A Faich
Journal: R I Med J Date: 1987-07

3. Lovastatin decreases coenzyme Q levels in humans.

Authors: K Folkers; P Langsjoen; R Willis; P Richardson; L J Xia; C Q Ye; H Tamagawa
Journal: Proc Natl Acad Sci U S A Date: 1990-11 Impact factor: 11.205

4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors: F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal: N Engl J Med Date: 1996-10-03 Impact factor: 91.245

5. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

Authors: Timo E Strandberg; Kalevi Pyörälä; Thomas J Cook; Lars Wilhelmsen; Ole Faergeman; Gudmundur Thorgeirsson; Terje R Pedersen; John Kjekshus
Journal: Lancet Date: 2004 Aug 28-Sep 3 Impact factor: 79.321

Review 6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors: Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal: Circulation Date: 2004-07-13 Impact factor: 29.690

Review 7. Carcinogenicity of lipid-lowering drugs.

Authors: T B Newman; S B Hulley
Journal: JAMA Date: 1996-01-03 Impact factor: 56.272

8. Severe irritability associated with statin cholesterol-lowering drugs.

Authors: B A Golomb; T Kane; J E Dimsdale
Journal: QJM Date: 2004-04

9. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke.

Authors: Tatjana Rundek; Ali Naini; Ralph Sacco; Kristen Coates; Salvatore DiMauro
Journal: Arch Neurol Date: 2004-06

Review 10. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications.

Authors: Peter H Langsjoen; Alena M Langsjoen
Journal: Biofactors Date: 2003 Impact factor: 6.113

9 in total

1. Impact of high dose statin trials on hospital prescribers.

Authors: Thomas I Barron; Kathleen Bennett; John Feely
Journal: Eur J Clin Pharmacol Date: 2006-11-18 Impact factor: 2.953

2. Should we lower cholesterol as much as possible? Policy on high dose statins is startlingly absent.

Authors: Martin G Duerden
Journal: BMJ Date: 2006-06-17

3. Long term safety of statins should be monitored.

Authors: Steven J Haas; Rosana Hage-Ali; Brian G Priestly; Andrew Tonkin; Lisa Demos; John J McNeil; Mark Nelson
Journal: BMJ Date: 2006-09-23

4. Strategies for prescribing statins.

Authors: Norbert Donner-Banzhoff; Andreas Sönnichsen
Journal: BMJ Date: 2008-02-09

5. Should we lower cholesterol as much as possible? Cholesterol is good?

Authors: Jacob F de Wolff
Journal: BMJ Date: 2006-06-17

6. Coenzyme Q10: is there a clinical role and a case for measurement?

Authors: Sarah L Molyneux; Joanna M Young; Christopher M Florkowski; Michael Lever; Peter M George
Journal: Clin Biochem Rev Date: 2008-05

7. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials.

Authors: Liam Smeeth; Ian Douglas; Andrew J Hall; Richard Hubbard; Stephen Evans
Journal: Br J Clin Pharmacol Date: 2008-11-05 Impact factor: 4.335

8. Hypolipidemia: a word of caution.

Authors: Rr Elmehdawi
Journal: Libyan J Med Date: 2008-06-01 Impact factor: 1.657

Review 9. Dyslipidemia and rupture risk of intracranial aneurysms-a systematic review.

Authors: Katja Løvik; Johnny Laupsa-Borge; Nicola Logallo; Christian A Helland
Journal: Neurosurg Rev Date: 2021-03-11 Impact factor: 3.042

9 in total